Do women with acute myocardial infarction receive the same treatment as men?

Abstract Objective : To determine whether women with acute myocardial infarction in the Nottingham health district receive the same therapeutic interventions as their male counterparts. Design : Retrospective study. Setting : University and City Hospitals,20Nottingham. Patients : All patients admitted with a suspected myocardial infarction during 1989 and 1990. Main outcome measures : Route and timing of admission to hospital, ward of admission, treatment, interventions in hospital, and mortality. Results - Women with myocardial infarction took longer to arrive in hospital than men. They were less likely to be admitted to the coronary care unit and20were therefore also less likely to receive thrombolytic treatment. They seemed to have more severe infarcts, with higher Killip classes, and had a slightly higher mortality during admission. They were less likely than men to receive secondary prophylaxis by being discharged taking ß blockers or aspirin. Conclusion : Survival chances both in hospital and after discharge in women with acute myocardial infarction are reduced because they do not have the same opportunity for therapeutic intervention as men.

[1]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[2]  R. Conroy,et al.  Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in women. , 1988, Journal of the American College of Cardiology.

[3]  M. Petticrew,et al.  Coronary artery surgery: are women discriminated against? , 1993, BMJ.

[4]  E. Gilpin,et al.  Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. , 1988, The American journal of cardiology.

[5]  A. Skene,et al.  Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. , 1992, British heart journal.

[6]  K. Uemura,et al.  Trends in cardiovascular disease mortality in industrialized countries since 1950. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[7]  A. M. Skene,et al.  Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction , 1993, The Lancet.

[8]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[9]  Dwight Lemon,et al.  Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1 , 1987 .

[10]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[11]  S. Willich,et al.  Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. , 1987, Journal of the American College of Cardiology.

[12]  C. W. Frank,et al.  Prognosis of women with newly diagnosed coronary heart disease--a comparison with course of disease among men. , 1973, American journal of public health.

[13]  W. Kannel,et al.  Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. , 1986, American heart journal.